RENEE BAYES: Open Payments
NPI 1255721536 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 25 payments from 14 companies in 2025. Trend: 2023 $214 · 2024 $543 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $199 |
| Novo Nordisk Inc | 2 | $59 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Intra-Sana Laboratories | 1 | $27 |
| Exact Sciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: VRAYLAR, Ozempic, JOURNAVX, RELTONE 200 MG, The Cologuard Plus Collection Kit, BREZTRI, OTEZLA, PREVNAR 20.
Industry payments across NV — which companies pay providers there.
